FDA Expands Use of ACAM2000 Vaccine for Mpox

FDA Expands Use of ACAM2000 Vaccine for Mpox

by
FDA Expands Use of ACAM2000 Vaccine for Mpox

The US Food and Drug Administration (FDA) has approved the expanded use of Emergent BioSolutions’ ACAM2000 smallpox vaccine to include people at high risk for mpox. This decision was announced on Thursday by the company. Earlier this month, the World Health Organization (WHO) declared mpox a global public health emergency for the second time in … Read more